ORF_ID	Contig	Start	Stop	Orientation	Cut_Off	Pass_Bitscore	Best_Hit_Bitscore	Best_Hit_ARO	Best_Identities	ARO	Model_type	SNPs_in_Best_Hit_ARO	Other_SNPs	Drug Class	Resistance Mechanism	AMR Gene Family	Predicted_DNA	Predicted_Protein	CARD_Protein_Sequence	Percentage Length of Reference Sequence	ID	Model_ID	Nudged	Note	Hit_Start	Hit_End	Antibiotic
BGC0000258.1|Prodigiosin_2 # 714 # 950 # -1 # ID=1_2;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.456	BGC0000258.1|Prodigiosin_2 	714	950	-	Loose	1900	22.7126	acrD	32.14	3000491	protein homolog model	n/a	n/a	aminoglycoside antibiotic	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	ATGTCCTGGATAACTTTATTTGCAAGATGGCGGCAAGCGAAAGGATACCGGTTATTGCACTCACATAGTGAAATCGTATTTTTATATTACATCATCTGGTTTGGCATGACGGCCCCTATACTTGCCATCATGCCAATGATTAATCCGAACGCTAATGGTTCAGGCGGACAACGTCAGGCTGTAAGTTTTATATCCCCCGGACAAATTCCGGGCGCGGAAGCCATGTTGCGTGAGTAA	MSWITLFARWRQAKGYRLLHSHSEIVFLYYIIWFGMTAPILAIMPMINPNANGSGGQRQAVSFISPGQIPGAEAMLRE	MANFFIDRPIFAWVLAILLCLTGTLAIFSLPVEQYPDLAPPNVRVTANYPGASAQTLENTVTQVIEQNMTGLDNLMYMSSQSSGTGQASVTLSFKAGTDPDEAVQQVQNQLQSAMRKLPQAVQNQGVTVRKTGDTNILTIAFVSTDGSMDKQDIADYVASNIQDPLSRVNGVGDIDAYGSQYSMRIWLDPAKLNSFQMTAKDVTDAIESQNAQIAVGQLGGTPSVDKQALNATINAQSLLQTPEQFRDITLRVNQDGSEVRLGDVATVEMGAEKYDYLSRFNGKPASGLGVKLASGANEMATAELVLNRLDELAQYFPHGLEYKVAYETTSFVKASIEDVVKTLLEAIALVFLVMYLFLQNFRATLIPTIAVPVVLMGTFSVLYAFGYSVNTLTMFAMVLAIGLLVDDAIVVVENVERIMSEEGLTPREATRKSMGQIQGALVGIAMVLSAVFVPMAFFGGTTGAIYRQFSITIVAAMVLSVLVAMILTPALCATLLKPLKKGEHHGQKGFFAWFNQMFNRNAERYEKGVAKILHRSLRWIVIYVLLLGGMVFLFLRLPTSFLPLEDRGMFTTSVQLPSGSTQQQTLKVVEQIEKYYFTHEKDNIMSVFATVGSGPGGNGQNVARMFIRLKDWSERDSKTGTSFAIIERATKAFNQIKEARVIASSPPAISGLGSSAGFDMELQDHAGAGHDALMAARNQLLALAAENPELTRVRHNGLDDSPQLQIDIDQRKAQALGVAIDDINDTLQTAWGSSYVNDFMDRGRVKKVYVQAAAPYRMLPDDINLWYVRNKDGGMVPFSAFATSRWETGSPRLERYNGYSAVEIVGEAAPGVSTGTAMDIMESLVKQLPNGFGLEWTAMSYQERLSGAQAPALYAISLLVVFLCLAALYESWSVPFSVMLVVPLGVIGALLATWMRGLENDVYFQVGLLTVIGLSAKNAILIVEFANEMNQKGHDLFEATLHACRQRLRPILMTSLAFIFGVLPMATSTGAGSGGQHAVGTGVMGGMISATILAIYFVPLFFVLVRRRFPLKPRPE	7.52	gnl|BL_ORD_ID|1309|hsp_num:0	1427			2826	2991	
BGC0000258.1|Prodigiosin_3 # 1714 # 2874 # 1 # ID=1_3;partial=00;start_type=ATG;rbs_motif=GGA;rbs_spacer=7bp;gc_cont=0.465	BGC0000258.1|Prodigiosin_3 	1714	2874	+	Loose	800	26.1794	Staphylococcus aureus LmrS	39.13	3004572	protein homolog model	n/a	n/a	macrolide antibiotic; aminoglycoside antibiotic; oxazolidinone antibiotic; diaminopyrimidine antibiotic; phenicol antibiotic	antibiotic efflux	major facilitator superfamily (MFS) antibiotic efflux pump	ATGGATTTTAACCTGTCAAATAGTCAGTCAGATATTTATGAGTCAGCGTATAGATTTGCTTGCGATGTATTAGATCAAGATGCACAAACGCGAATATCACAGAAGATTTTAAGTACTGAATTATGGAAAAAGGCCGCTGCTTATGGATTTGCACATGGTCCGGTTTCTCACCAATTTGGCGGCTCGGAGCTGGGGGCGCTTGATACTGCATTGATGATCGAGGCCCTGGGAAAAGGAAGCCGTGATATTGGATTATCGTTTTCATTATGCGCCCATTTATGCGCTTGTGTTATTCCTCTCTATCGTTTTGGTTCAAGTGAATTGAAAGATAAATATCTTGAATCGTTAGTGACCGGGAAATTAATTGCAGCGAATGCGGCCACCGAACCTGATGCAGGTTCCGATATTTACAATATGCAGGCGACAGCCCAACCCTGCGAGGGGGGATATATTCTTAATGGGAAAAAGATTTTTATTACCAATGCGCCGATTGCCGATGTATTTATCATCTATGCGAAAACAAATCCTGATCACGGGTTCCTGGGCGTGTCGGCCTTTCTTATCGAGAAAGGCACGCCGGGCCTGAACGTAGGGGAGGTGATCCCGAAAGATTGTCTTTCTAATTGCCCCTGGAGTGAGATCGTTTTCAACGACATTTTTATTCCTCAATCACAGCGTATCGGGATGGAAGGTGCGGGCGGGGCTATTTTCCATGATTCAATGATTTGGGAAAAAGGCTGTTTGTCGGCCCTGTTTGTGGGGGGATTGGCGCGCCTTTTAGAAACGACCCTAGAGTATGCCAAAGCGCGCCAGCAATTTGGTAAGGCGATCGGTCAGTTCCAATCTGTCTCTAATCGAATTATCGATATGAAACTGCGCCTGGAGCAGTGTCGGTTGATGCTCTATCGCGCCTGTTGGAAACATGATCAGGGTCAGGATGCCGAAGCCGATATCGCCATGAGTAAACTGCTGATTTCCGAGTACGCGGTTCAATCCGGTCTGGATGCCATTCAAACTTTTGGCGGAGCAGCGATGGATCAGGAACTCGGCCTGGTTCGCCATCTTTTGAATATGATCCCGAGTCGAATTTTCTCCGGTACCAATGATATCCAGAAAGAGATTATTGCCCGTAAACTCGGTTTAAGGGGAACATCATCATGA	MDFNLSNSQSDIYESAYRFACDVLDQDAQTRISQKILSTELWKKAAAYGFAHGPVSHQFGGSELGALDTALMIEALGKGSRDIGLSFSLCAHLCACVIPLYRFGSSELKDKYLESLVTGKLIAANAATEPDAGSDIYNMQATAQPCEGGYILNGKKIFITNAPIADVFIIYAKTNPDHGFLGVSAFLIEKGTPGLNVGEVIPKDCLSNCPWSEIVFNDIFIPQSQRIGMEGAGGAIFHDSMIWEKGCLSALFVGGLARLLETTLEYAKARQQFGKAIGQFQSVSNRIIDMKLRLEQCRLMLYRACWKHDQGQDAEADIAMSKLLISEYAVQSGLDAIQTFGGAAMDQELGLVRHLLNMIPSRIFSGTNDIQKEIIARKLGLRGTSS	MAKVELTTRRRNFIVAVMLISAFVAILNQTLLNTALPSIMRELNINESTSQWLVTGFMLVNGVMIPLTAYLMDRIKTRPLYLAAMGTFLLGSIVAALAPNFGVLMLARVIQAMGAGVLMPLMQFTLFTLFSKEHRGFAMGLAGLVIQFAPAIGPTVTGLIIDQASWRVPFIIIVGIAILAFVFGLVSISSYNEVKYTKLDKRSVMYSTIGFGLMLYAFSSAGDLGFTSPIVIGALILSMVIIYLFIRRQFNITNALLNLRVFKNRTFALCTISSMIIMMSMVGPALLIPLYVQNSLSLSALLSGLVIMPGAIINGIMSVFTGKFYDKYGPRPLIYTGFTILTITTIMLCFLHTDTSYTYLIVVYAIRMFSVSLLMMPINTTGINSLRNEEISHGTAIMNFGRVMAGSLGTALMVTLMSFGAKIFLSTSPSHLTATEIKQQSIAIGVDISFAFVAVLVMAAYVIALFIREPKEIESNRRKF	80.42	gnl|BL_ORD_ID|2869|hsp_num:0	3276			1173	1305	erythromycin; streptomycin; kanamycin A; linezolid; trimethoprim; chloramphenicol; florfenicol
BGC0000258.1|Prodigiosin_4 # 3861 # 4883 # 1 # ID=1_4;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.524	BGC0000258.1|Prodigiosin_4 	3861	4883	+	Loose	2000	29.261	oqxB	40.0	3003923	protein homolog model	n/a	n/a	fluoroquinolone antibiotic; glycylcycline; tetracycline antibiotic; diaminopyrimidine antibiotic; nitrofuran antibiotic	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	ATGGAGTTGCTCGATAATATTTCCCTTTACACCTATTTGTTTGAGCCGGATAAGCTTGGCCGGTTACCGGAACAGCTGCGGCCACCCGCCAGACTGGGTAAACTGGTTGAGAATGCAGTATCCACCACCTTGCGGGTTGAGTGTCTGGATATTCATGATGTCTCTGCCTATGTCGGTTTGCACTTTCTGGTGGGCTATCTGCGCGGAAACCTGGTCACCCTGCCTGGCGGTAATGGCAGTATCAGTGCGGGGTTGTGTAAGTATCTAAGCCATCAGCGCAATGTCACGTTGCAAAACCATGTCCAGTTGACAGCGGTTGAGCCGCAGCACAATGGTACATGCATCCAGTTCACGATCAATGGTCAACCCCGCCAAGTGCAGGCTCAACAGATCATTTGGGCCGCGCCTAAAACGCAACTTGCCACATGGCTGCCGGGATTGCCGGCCAAACAGTTGGCGGCCATCAAGAACATTCGTCATGAAGACTACTATCTGGCGAATGTATTCCTGTCAAAACCGGTGCTGGGTCATTCGTTTGGTGGCTATATGATCGAACCGGACAGCAATAAAGATCCGTTCTCTTGGTGTAAAGCGGGGACTTGCCTGGTGGCCAACTGGATGGACGATCATGCTGACGTGGATGTGGGCGTGCTGACATTGCTTAAACCCACGACGCGCTCAGAGCGGCAAGACCGTACCGCACAGAATGCGTTTTTAGCGCTACAACAGCAAACCTATGCCGAAATTGCCAAGGTTCTGCGCAACATAGGGATTGGTGCCGAGGTTATTGAGGATATCCAGATCTGGTATTGGCCCGCAGGGCTGGTGACGTCGGTAGTGGGGCAACAGGCTGAAGGTGTATTCGAAACCGCCCGTCAGTCATTTGAAAATATTCATTTCGCTAATCAGGACAGTGTCGGTGTCGGCAATATCGAGAGTGCCATCCTGTCGGGAATTGATGCAGCCAACGCGGTTAAAGCGCAACTCATGGATACGGAAAATGTCGTGGAGGTGGCGGGATGA	MELLDNISLYTYLFEPDKLGRLPEQLRPPARLGKLVENAVSTTLRVECLDIHDVSAYVGLHFLVGYLRGNLVTLPGGNGSISAGLCKYLSHQRNVTLQNHVQLTAVEPQHNGTCIQFTINGQPRQVQAQQIIWAAPKTQLATWLPGLPAKQLAAIKNIRHEDYYLANVFLSKPVLGHSFGGYMIEPDSNKDPFSWCKAGTCLVANWMDDHADVDVGVLTLLKPTTRSERQDRTAQNAFLALQQQTYAEIAKVLRNIGIGAEVIEDIQIWYWPAGLVTSVVGQQAEGVFETARQSFENIHFANQDSVGVGNIESAILSGIDAANAVKAQLMDTENVVEVAG	MDFSRFFIDRPIFAAVLSILIFITGLIAIPLLPVSEYPDVVPPSVQVRAEYPGANPKVIAETVATPLEEAINGVENMMYMKSVAGSDGVLVTTVTFRPGTDPDQAQVQVQNRVAQAEARLPEDVRRLGITTQKQSPTLTLVVHLFSPGGKYDSLYMRNYATLKVKDELARLPGVGQIQIFGSGEYAMRVWLDPNKVAARGLTASDVVTAMQEQNVQVSAGQLGAEPLPQESDFLISINAQGRLHTEEEFGNIILKTAQDGSLVRLRDVARIEMGSGSYALRSQLNNKDAVGIGIFQSPGANAIDLSNAVRAKMAELATRFPEDMQWAAPYDPTVFVRDSIRAVVQTLLEAVVLVVLVVILFLQTWRASIIPLIAVPVSVVGTFSILYLLGFSLNTLSLFGLVLAIGIVVDDAIVVVENVERNIEEGLAPLAAAHQAMREVSGPIIAIALVLCAVFVPMAFLSGVTGQFYKQFAVTIAISTVISAINSLTLSPALAALLLKPHGAKKDLPTRLIDRLFGWIFRPFNRFFLRSSNGYQGLVGKTLGRRGAVFAVYLLLLCAAGVMFKVVPGGFIPTQDKLYLIGGVKMPEGSSLARTDAVIRKMSEIGMNTEGVDYAVAFPGLNALQFTNTPNTGTVFFGLKPFDQRKHTAAEINAEINAKIAQIQQGFGFSILPPPILGLGQGSGYSLYIQDRGGLGYGALQSAVNAMSGAIMQTPGMHFPISTYQANVPQLDVQVDRDKAKAQGVSLTDLFGTLQTYLGSSYVNDFNQFGRTWRVMAQADGPYRESVEDIANLRTRNNQGEMVPIGSMVNISTTYGPDPVIRYNGYPAADLIGDADPRVLSSSQAMTHLEELSKQILPNGMNIEWTDLSFQQATQGNTALIVFPVAVLLAFLVLAALYESWTLPLAVILIVPMTMLSALFGVWLTGGDNNVFVQVGLVVLMGLACKNAILIVEFARELEIQGKGIMEAALEACRLRLRPIVMTSIAFIAGTIPLILGHGAGAEVRGVTGITVFSGMLGVTLFGLFLTPVFYVTLRKLVTRRKPVQEDLPA	32.38	gnl|BL_ORD_ID|2152|hsp_num:0	2400			855	945	tigecycline; ciprofloxacin; nitrofurantoin; trimethoprim
BGC0000258.1|Prodigiosin_5 # 4880 # 7552 # 1 # ID=1_5;partial=00;start_type=ATG;rbs_motif=GGA;rbs_spacer=9bp;gc_cont=0.525	BGC0000258.1|Prodigiosin_5 	4880	7552	+	Loose	1500	259.61	rphA	27.31	3000444	protein homolog model	n/a	n/a	rifamycin antibiotic	antibiotic inactivation	rifampin phosphotransferase	ATGAATCAACCACTGGTTGTTGAAATATCCGGTGATAAGGCGCTTGAACATCACCACTTGGGCGGTAAGGGTTATTCACTCAACAACCTGATTCATGCGGGCCTGCCAGTACCTTCGGCATTTTGTGTGACGGCACAAGCCTACCAACAGTTTATTGAAGAGGTGGTGCCGGGGGCGGAATTAACTGACGGCGACCTGATTGCGGTGCGTGACGCCATCCTGCATGCCGATATTCCCGACTCGCTAAAGCAGGCTATCGGTGATGCTTATCAACACCTGGGCCATGACACGACCATTGCGGTTCGTTCTTCGGCATTGGATGAAGATGGTCAACGTCAGTCATTTGCCGGGCAGTACGAGACTTACCTGCATGTGAAGGGTTCAGAGGCAGTGTTGCACAAGGTTCAGGCTTGTTGGGCGTCGCTTTGGGCTGAGCGAGCGGCTCAATATCGTCATGAATCTGCGTCGCACAGTGCCATTGCCGTGATTCTACAAGTGATGGTTGATGCCGATGCAGCGGGAGTGATGTTTACTCAGGATCCTCTGTCAGGGAGCACCGATAAGGTGGTGATTGACAGTTGTTGGGGGCTGGGGGAAGGCGTGGTTTCCGGGCAAGTCACCACAGATAGTTTCACGCTGGATAAAGCCACCGGTGAGCTATGTGATCAGCAGATTCGCCACAAACCGAATTACTGCCAGCGGGACGAACATGGTCTGGTGACACTGTTGCAAACCCCGGAGGCCAAACGGGATCTCCCCAGTCTGACGCCGGCTCAGTTGCAACAGTTGGTCACGCTGGCCAGACAGGCCCAGCTTATCTACAGCACCGAACTGGATATTGAATGGGCGGTGAAAGATGACAAAGTCTGGTTATTACAGGCGCGTCCGGTAACCACATCGGCCAAAACGGCTAACGTTATCTACGCCAATCCGTGGGAGAGCGACCCGGCTGCGAAGGAGGGCGCTTTTTTCTCGCGGATGGATACCGGAGAGATTGTGACGGGGCTGATGACGCCACTGGGGTTGTCATTTTGTCAGTTCTATCAAAAGCACATTCATGGCCCGGCCATCAAGACCATGGGGCTTGCCGATATTAGTCACTGGCAGATCTATATGGGCTATATCCAGGGCTATGTTTATCTGAATATTTCCGGTTCGGCCTATATGCTCAGGCAGTGTCCACCGACCCGTAATGAAATGAAGTTCACCACCCGCTATGCCACGGACGAGATCGATTTTAAGGACTATAAAAACCCCTATGGTGCAGGCGTGCAGGGCTGGGATTATGCCAAGAGTTGTTGGTACTGGCTAAAACAGCAAGTCCGTAATATGCGCAGCGCCGCCAGGACCGTCGAGCAGATGATTGCCCTGCGTCAGGACGAAACCACACGGTTTCTGGGGCTTGATTTGACCGCCATGACGCTTCAGCAGTTGGACCAAGAGCTGCAACGGATTGACCGCTTTTTCCTCGATAGCTGTGCGGCGTATATGCCTTTTTTCCTGCAATCATTTGCCCTTTACGATGCGCTGGCGCAAGCCTGTGAACGCCATATCAAGGATGGTAAAGGTCTGCAAAATCGCATCAAGGCGTCAATGAATAACCTGCGCACGATCGAAGTGACGCTCGGTATCATCAAATTGGTTGCGACAGTTAACCAACAGACTGAATTAAAAGCGTTATTTGAACAGCATCGTGCCGATGAGTTAGTCACCTTGCTACCTGTCCATGACATATCCCGTGCTTTCTGGCAGGGTGATTTTGAAGATTTTCTGGTTGAATTTGGTTCTCGCGGTCGCCAGGAGTTTGATCTGAGTATCCCGCGTTGGCGTGATGACCCGAGTTATTTATTGCAAGTAATGAAGATGTATTTGCAACACCCGGTAGATTTGCACAAGAAGCTCAGGGAAACGGAACTGCTGCGTCAGCAGGATAGTGAAGCACTGTTCAGTGCGATGTCCTGGTCGGGCCGTTTCAAGCTCAAAACCCTCATCAAGCTGTATGGCATGATGGCCGAACGTCGTGAAGCGACGCGGCCAACGTTTATCACCGAAACCTGGTTCTACCGTTGCATCATGCTGGAAGTTCTACGGCGTCTGGACGCGCAGGGGATTGCCAGTAGTGCCGATCTGCCCTATGTCGATTTTGAACAGTTCCGTGCGTATGTGGCGGGGACCATCCCAGCTGAACAGGCGTTTTCCAAAGCGCGGCTCGATCAGAATCGCCATCAACATTTATTCAATTTACATGCCGAAGAACCGCCGATGGCGATTGTCGGTCCCTATACCCCCAAAGTGAAAGCACCCACGCAGGATGATAAAACCATCCGGTCACTCACTGGCCTGGCGGCCAGTCCTGGCAACGTAGTGGCCAAAGCGCGGGTGATTACTGACTTGCAGGTCCAGGCCGGTGAGTTCCAGCCAGACGAAATTCTGGTTGCTCGTTTTACCGATGCCAGTTGGACGCCGTTATTTGCCCTGGCGGCCGGTATTGTCACGGATATTGGTTCCACACTTTCACACAGTTGTATTGTCGCGCGTGAGTTTGGGATCCCCGCCGTGGTGAACCTGAAAACCGCCACCCAGATTATCAATAGTGGCGACATGTTGATCCTTGATGGAGATAGCGGGACGGTCATTATCCAACACCAAGAGGAGCGCAACCATGACGGTTAA	MNQPLVVEISGDKALEHHHLGGKGYSLNNLIHAGLPVPSAFCVTAQAYQQFIEEVVPGAELTDGDLIAVRDAILHADIPDSLKQAIGDAYQHLGHDTTIAVRSSALDEDGQRQSFAGQYETYLHVKGSEAVLHKVQACWASLWAERAAQYRHESASHSAIAVILQVMVDADAAGVMFTQDPLSGSTDKVVIDSCWGLGEGVVSGQVTTDSFTLDKATGELCDQQIRHKPNYCQRDEHGLVTLLQTPEAKRDLPSLTPAQLQQLVTLARQAQLIYSTELDIEWAVKDDKVWLLQARPVTTSAKTANVIYANPWESDPAAKEGAFFSRMDTGEIVTGLMTPLGLSFCQFYQKHIHGPAIKTMGLADISHWQIYMGYIQGYVYLNISGSAYMLRQCPPTRNEMKFTTRYATDEIDFKDYKNPYGAGVQGWDYAKSCWYWLKQQVRNMRSAARTVEQMIALRQDETTRFLGLDLTAMTLQQLDQELQRIDRFFLDSCAAYMPFFLQSFALYDALAQACERHIKDGKGLQNRIKASMNNLRTIEVTLGIIKLVATVNQQTELKALFEQHRADELVTLLPVHDISRAFWQGDFEDFLVEFGSRGRQEFDLSIPRWRDDPSYLLQVMKMYLQHPVDLHKKLRETELLRQQDSEALFSAMSWSGRFKLKTLIKLYGMMAERREATRPTFITETWFYRCIMLEVLRRLDAQGIASSADLPYVDFEQFRAYVAGTIPAEQAFSKARLDQNRHQHLFNLHAEEPPMAIVGPYTPKVKAPTQDDKTIRSLTGLAASPGNVVAKARVITDLQVQAGEFQPDEILVARFTDASWTPLFALAAGIVTDIGSTLSHSCIVAREFGIPAVVNLKTATQIINSGDMLILDGDSGTVIIQHQEERNHDG	MSGRLVVDLQDVDAAGLAEVGGKGAHLGELSRIDGVRVPSGFCVTTHAFRRIMAEAPESGELLDRLSRVDEGDQEAVRSLAARLRQVVGATPLPDEVAAAVTGALARHGERSAYAVRSSATAEDLPTASFAGQQDTYLNVVGTEEILRHVSRCWASLFTERAVTYRGRQGVDHRTVHMGVVVQRMVVPRASGILFTADPVTGDRRTATVDAGFGLGEALVSGLVDPDVLTVRHGEVVARTIAAKRRALHAVQGGGTRETPIEERRQREPVLTDDQAVELVALGRRIEAHFGSPQDIEWCLDDDGFHIVQSRPITTLFPVPERDDDVFRVYLSVGHQQMMTDAMKPLGLSMWRLTALAPMYEAGGRLFVDATARLAVPGSRATLLDVVGRGDPLTRDALETVLENGEFEPTPAETDGGAPPAGDGAEPDEADPSIVTELIERSRRSLAELEREIGTKSGPALFAFLREAFEEHKRVVGDPLNIRAIMAGMEATWWLNDRLEEWLGEKNAADTLTLSAPDNVTSEMGLELLDVADVVRTHPEVVAFLEGVEDDGFLDELPKVPGGAEARDAFEAYLDRYGMRCVGEIDITXPPVRERPSALVPVVLDHVRAFGPGAAARRFEDGRRRALAKEREVLERLRDLPDGERRADAARRMIRQVRAFAGYREYPKYAIVSRSFVYRQALLREADELVRAGVLADREDVHYLTFDEFEEAVRVRRVDERLVRRRKDAFRSYQALTPPRVLTSEGVALSGAYRRDDVPEGALAGLAVSAGTVEGRARVVLDMAEADLEAGDILVTRFTDPSWSPLFVGIAGLVTEVGGLMTHGAVIAREYGLAAVVGVERATRLIRDGQRIRVHGTEGYIELLS	102.89	gnl|BL_ORD_ID|890|hsp_num:0	910			0	2583	rifampin; rifaximin; rifabutin; rifapentine
BGC0000258.1|Prodigiosin_6 # 7715 # 10315 # 1 # ID=1_6;partial=00;start_type=ATG;rbs_motif=AGGA;rbs_spacer=7bp;gc_cont=0.508	BGC0000258.1|Prodigiosin_6 	7715	10315	+	Loose	275	30.8018	AAC(6')-34	32.76	3003989	protein homolog model	n/a	n/a	aminoglycoside antibiotic	antibiotic inactivation	AAC(6')	ATGACAACCATGATAGGACAAACAAGACAAGCAGGCTCCTCTTCTTATGAGCAGGCTTGGCAAGCAGAACAAGCCCCCTGTCCAGGGATGGAGCCCGATACCCTCACTGTGGGTGTGGTGGTAGTGACGCGCAATCCCACATTTTTTCAAACCGGGCTCAGCGTGTTAAATGATATTCGCGACTATGTGTTCAATCGTGTGCATATTCAATCGGAACTTCCGCTGAAGTTATCTGAATTAGCGTCGGACCCGCTTTATTCCGAAGCCCGCGAAAAAGCGATTCATTTTCTAAAAAATCAGAGCAAGGCGCTCAATATTCAAGTCATCCAGTGTGCCAGTCTTGCCGAAGCGACGGGGAAAATTATTTATACCCATGCTCTGGAACAGCAGCCTGAATTTCAGATGGGAATGTTGTTTTACGATCAAACCTCGTTGGGGAATGTTGACGACAGCATTGAGAAAATTGACCGGGATCTGGACGCGTTTTATAGCGCCATGCAGAGAGGTGGGATCCCCGCTTTTTATACCACTTTCTCAACAGTAACCTTTATTCGTGATGTCCGTTCGTCGTTTCGTTATCTACCCCAGCAGTATCGAGAAATTGTCCGCAGTGAAGACCCCGCCATCTTCCAAACCGAACTGCTGTGTTTGTGGATGGACTTTTTTGAGATGAATTATACCAACCGCCGTGTCAAACCGATTGGGGCGTTGGCACTTCATAACACCCTGGCCGAGCAACTGATTCAGTTCTTTGAGCGCACTGCCGCCAGCCGTTGGTTGGTGTCTTACTATACCGGTTCGATCATCTCTAATCTGATCGGTTATCTGGACAGACATGCTGAAGCGCATGGTGCGTTAGTTCTGCGTGGCCCTAACGAACATGCCATTGCCTGTGGCGCCATGGCGAACTGGCAGCTTTATCGCATGCCTTTTCTGGGGGTAGTGACCTCCGGCATGATGGATGAATTTAAAGGCACGCTGATCAATCTGAAAGAGACGGCAGCACAGGGCATCATTGTTGCCGCAGAGAATCGTAATAATCAGTGGTATAGCTTCCAGGGCACACAGACGCCGACTGAAGATATGCGCGATGTCCTGGCCGCCAAGCGCATTCCGTATGTCTACATTGATGATGTTGACGGGATTGCTGATGGCCTGGCTGAAGTGTTTCGGCTCTACCATCAGGCCCAGGGGCCGGTAGTTATTTTAGCGACGCAAAATGTACTGGAATCGACTCTCTCGTTGGAGCCGGTGCCGGGTGACTTGCCGCCGGTTTCTGGTTTGCCAGCCTATGACTGCCCACCGATAAGCGACAGTTTTGAGCAAGCCATGGCGCTGATTAATGAAGGGCCGGAAAAACTGGTTTGGCAGTTAGGACCGGTCAGTGACGATGAGTATGCCCTGGTTCATGAAATTGCCGATGCTGCCGGCCTGGCGCTGGTGGATTCGTTAGCGCATCCGGGTTCGGCACCGAAATATTATCAGGGCAAGCGCAATCCCCACTATTTGGGAACCCTGGCCATTTATGGTTATAGCCCCCGGGTTTACAACTTCCTGCATACCAACGACAAACTCAATCCAATGAGTGATCAAAGTGTGTTTATGATCAAAAGCCGTGTGGCGCAGATCACCACGCCGTTCTCTGATGGTCGGCTCGAGCGCAAGGTGCATTTGGTACAACTCACGCACGATGAACGACACTTATCGCCGTACGCCGATTTGAAACTGCATATGGATTGCCTGACTTTCCTCCGGGCGGTGAAAGCCAATCTGCATGTCGATGCGGCACTACGGGAGAAACGCAAAGCGCTCATCGCTGCCTATCTGGATTCCCCTTCAGATGTTGTTAGCCAGTTACCCAGCCTGCCGATGTCGGCGAACTACTTTTTTTGCCAATTGAATCGGGTTATCGAGAATTTAATCAAGACGGAAAATTTCGATTTTACCGGGGTTTACGATGTGGGGCGCTGTGGTATTTCAGCGGTACGCAATGTTGCCAAGACGCGGCGCGGTTTCTCGGGTTGGTATGGTCGGGCCTTGATGGGCGATGCATTACTGGCCACCAGCTATCTGGCGCATACCAGTCCCACCCATGTGGTGGCGTTTATCGGCGACGGGGCCAAAGGGATTGTGCCGGATATTTTACCCGCCTTTATCGACAACATTCTCACCCATCCGCAGTTACTCAATAAAAGCATCACCATTTTCTATTTTTGCAATGGCGGCTTGTCGGTCATCAACACCTATCAGGAACGTATTTTGTTTAACCGCACATCGCGGCAGATGCGCCTGGTGAACGTTGATCAACCCGCGTTTGAACAGACGGTGGATGATTTTCATATTCAGGGTAAAACACTCACTCATTTTGATGAGGACACCATTCGTCATGCATTGATGACCCCCAAACGACTGAACCTGTTTTCAGTGGTACTGGGGCATAACAATGAAGGGGATGGCATTTCGTTAGCCACAGCCAAAGGCTGGCAACGCGACCCCAGCGACCGGGAAGCGCTGCAAGAGCGTAAAGACTGGGCGGCTCGCCAGCCCGAATCGACAAGCACTTCATTCGACCAAGGTCAAAACAAGGAAGCTATATCATGA	MTTMIGQTRQAGSSSYEQAWQAEQAPCPGMEPDTLTVGVVVVTRNPTFFQTGLSVLNDIRDYVFNRVHIQSELPLKLSELASDPLYSEAREKAIHFLKNQSKALNIQVIQCASLAEATGKIIYTHALEQQPEFQMGMLFYDQTSLGNVDDSIEKIDRDLDAFYSAMQRGGIPAFYTTFSTVTFIRDVRSSFRYLPQQYREIVRSEDPAIFQTELLCLWMDFFEMNYTNRRVKPIGALALHNTLAEQLIQFFERTAASRWLVSYYTGSIISNLIGYLDRHAEAHGALVLRGPNEHAIACGAMANWQLYRMPFLGVVTSGMMDEFKGTLINLKETAAQGIIVAAENRNNQWYSFQGTQTPTEDMRDVLAAKRIPYVYIDDVDGIADGLAEVFRLYHQAQGPVVILATQNVLESTLSLEPVPGDLPPVSGLPAYDCPPISDSFEQAMALINEGPEKLVWQLGPVSDDEYALVHEIADAAGLALVDSLAHPGSAPKYYQGKRNPHYLGTLAIYGYSPRVYNFLHTNDKLNPMSDQSVFMIKSRVAQITTPFSDGRLERKVHLVQLTHDERHLSPYADLKLHMDCLTFLRAVKANLHVDAALREKRKALIAAYLDSPSDVVSQLPSLPMSANYFFCQLNRVIENLIKTENFDFTGVYDVGRCGISAVRNVAKTRRGFSGWYGRALMGDALLATSYLAHTSPTHVVAFIGDGAKGIVPDILPAFIDNILTHPQLLNKSITIFYFCNGGLSVINTYQERILFNRTSRQMRLVNVDQPAFEQTVDDFHIQGKTLTHFDEDTIRHALMTPKRLNLFSVVLGHNNEGDGISLATAKGWQRDPSDREALQERKDWAARQPESTSTSFDQGQNKEAIS	MRIGDLIREDGGIAMLVYEAGPITVRELEEKDEISLASWLSNPDVLQYYEGRDNPHDVERVREHFYVDDDETRCIIKYEGKPIGYIQFYLLDEETLGEYGYNESDADCRTFATDQFIGEPDYWNRGIGTKLMTSMVEYLVFQRQADRIVMDPQAWNERAIACYEKCGFRKVRLLEKHEQHEGELRDCWIMEYRAERK	439.59	gnl|BL_ORD_ID|2233|hsp_num:0	2525			15	168	kanamycin A
BGC0000258.1|Prodigiosin_7 # 10312 # 12873 # 1 # ID=1_7;partial=00;start_type=ATG;rbs_motif=AGGA;rbs_spacer=9bp;gc_cont=0.531	BGC0000258.1|Prodigiosin_7 	10312	12873	+	Loose	1000	26.9498	lsaB	31.03	3003111	protein homolog model	n/a	n/a	lincosamide antibiotic; streptogramin antibiotic; pleuromutilin antibiotic	antibiotic target protection	lsa-type ABC-F protein	ATGAAGTTTGGATTTATCGCTCATCCAACCTCGGTTGGTTTAAAACGCTATGTCAAAATGATTGATTTATTACAGCGTAATTCGACGGAGTTGCATAGCGGGTACAAACGAGACCTTTGGCGCCGGGAAAACCTGGTCCCTTTCATGAACTTTGCCAAAATTACCTCAGCGACCGGCGCTACCTGTGAGGGAGTGATCAAATACATGCCGCTGGTCGCGGATGAGATGCTGGCTGATGCTCGCGGCATTGCCAATCGTGTGGTGTCGGGTATCGAAGAACTGGTCGAGGATGGCGCTGAACTGGTCGGTTTGGGAGGATTCACCTCCATTGTCGGGCGGCGTGGTGAAGCCACCGCCGAGAAATCACCGGTTCCGGTGACCTCCGGTAATTCGTTAACCACCTATGCGGGTTACAAAGCGCTGATGCAGATTCAGTCCTGGCTGGATATTCAGCCAGAGCAGGAGCCGGTTGCGATTGTCGGCTATCCGGGCTCCATCTGTTTGGCGCTGAGCCGGTTATTGCTCGCCCAGGGTTTTTCCCTGCATTTGCTGCATCGGGCCGGCCATAAAGATGAAGACGAATTGCTCAGCCATTTGCCGGAGCAATATCGCTCACGCGTCACGTTGACCAGTGATCCCGAGGATTTATACCCGCGTTGTAAACTGTTTGTCGCCGCAACATCCGCCGGAGGCGTGATTGACCCGTATAAACTGCAACCGGGTTCGGTCTTTATTGATGTGGCACTGCCCAGAGATATCAATTCTGACACGCGTCCCGATCGGGACGACATTTTGATTATCGACGGCGGCTGCGTTACGGCCACCGATGCGGTCAAACTGGGTGGTGAGTCACTGAACGTCACCATTAAACAGCAATTGAATGGCTGTATGGCGGAAACCATTGTTTTGGCACTGGAAAATCGCCGGGAGAATTTCTCGTTGGGCCGCTATCTGGCGCTGGATAACGTGCTTGAAATCGGGGAACTTGCGGAAAAACATGGTTTCCTGGTCTATCCACTGGCCTCTTATGGTGAGCGGATTGATCGTCAACGGGTGATCAATCTCAAGCGTTACTATCACCATGATATTTATTCCGATGAACCTGATACTGAACAACCGCCGGCGTCGCAGTTAGCCTTTATCGACGCGATTATTGCTCAGGATCCCGCCAGAGAAGACACTCTGGATCGCTATCATCAGTTCATTAACCCGATGATGGTGGAATTTCTCAAACTGCAACACTGTGACAATGTATTCCGGCGGGCCTCGGGTACTCAGCTGTTTACCGCTGACGGCGAAGCCTTTCTGGATATGGTGGCCGGTTATGGTTGCATCAATCTGGGTCACAATCCGCAACCGATCATCGATGCTTTAAAAGCCTATCTCGATGCTCAGGGGCCCAATTTTATTCAGTATATTTCGATCCCCGAGCAAGCTGCCAAGTTGGCCGAAGTGCTCTGCCATTTCGCCCCTGGCAATATGGGGAGGGTGTTCTTCAGTAATTCAGGGACGGAGGCGGTCGAGGCGGCAATGAAGCTGGCCAAAGCGTCGACGGGCAAAGCCGGCATTGCGTATCTGAAAAATAGCTACCATGGCAAAACGCTGGGCGCGTTATCCATTACCGGACGAGAAAAACACCGCCGTCATTTTAAGCCACTGCTGGCGTCGATGATTGAAGTACCGTTTGCTGATATTGAGGCACTGCGGCAGACCTTAAGCCGTGATGACATCGGCGCGTTGATGATCGAACCGATTCAGGGTGAAGGCGGGGTCCATGTTCCTCCGCCTGGATACCTGCGAACCGTTCAGGAGATCTGCCGTCAAACCGATACCTTACTGATGGTTGACGAAGTGCAAACCGGGTTGGGGCGCACCGGGAAGCTCTTTGCCTGTGAGTGGGAAGGGATCGAGCCGGATGTACTGATGCTATCGAAATCACTGTCCGGCGGGGTAATGCCTATTGGCGCCACGCTATGTCGGGCCATATTTGGCAACGGGCCGTATGGCACCGCAGACCGCTTTTTGATGCACAGCTCGACCTTTGGCGGCGGGAATATCGCGGCGGTAGTGGCGCTCAGTGCGTTAAGAGAAATTCTGGCTCAGGATCTGGTCGGGAACGCCGAGCGACTAGGCACGTACTTTAAGCAGGCGCTTACCGATGTCGCTGCCCGATACCCCTTTGTGGCGGAAATAGCCGGACGCGGCTTGATGTTAGGGATCCAGTTCGATCAAACCTTCGCTGGTGCCGTAGGTGCTTCGGCCCGGGAGTTTGCCACCCGACTGCCCGGTGACTGGCACACGACATGGAAATTCCTGCCTGATCCGGTACAAGCCCACTTAAAGGCGGCGATGGAGCGTATGGAACAATCACTGGGTGAAATGTTCTGCATGAAATTTGTGACCAAGCTTTGTCAGGATCACAACATTCTGACCTTTATTACCGCCAACAGCTCAACCGTTATTCGAATTCAACCGCCACTGACCATCAGCAAGGCTGAGATCGATCGTTTTGTCAGTGCGTTTGCCACGGTGTGCGATGAGCTATCAACATTTTTAGAGTAA	MKFGFIAHPTSVGLKRYVKMIDLLQRNSTELHSGYKRDLWRRENLVPFMNFAKITSATGATCEGVIKYMPLVADEMLADARGIANRVVSGIEELVEDGAELVGLGGFTSIVGRRGEATAEKSPVPVTSGNSLTTYAGYKALMQIQSWLDIQPEQEPVAIVGYPGSICLALSRLLLAQGFSLHLLHRAGHKDEDELLSHLPEQYRSRVTLTSDPEDLYPRCKLFVAATSAGGVIDPYKLQPGSVFIDVALPRDINSDTRPDRDDILIIDGGCVTATDAVKLGGESLNVTIKQQLNGCMAETIVLALENRRENFSLGRYLALDNVLEIGELAEKHGFLVYPLASYGERIDRQRVINLKRYYHHDIYSDEPDTEQPPASQLAFIDAIIAQDPAREDTLDRYHQFINPMMVEFLKLQHCDNVFRRASGTQLFTADGEAFLDMVAGYGCINLGHNPQPIIDALKAYLDAQGPNFIQYISIPEQAAKLAEVLCHFAPGNMGRVFFSNSGTEAVEAAMKLAKASTGKAGIAYLKNSYHGKTLGALSITGREKHRRHFKPLLASMIEVPFADIEALRQTLSRDDIGALMIEPIQGEGGVHVPPPGYLRTVQEICRQTDTLLMVDEVQTGLGRTGKLFACEWEGIEPDVLMLSKSLSGGVMPIGATLCRAIFGNGPYGTADRFLMHSSTFGGGNIAAVVALSALREILAQDLVGNAERLGTYFKQALTDVAARYPFVAEIAGRGLMLGIQFDQTFAGAVGASAREFATRLPGDWHTTWKFLPDPVQAHLKAAMERMEQSLGEMFCMKFVTKLCQDHNILTFITANSSTVIRIQPPLTISKAEIDRFVSAFATVCDELSTFLE	MSMIHVQNLTFSYPSSFDNIFEDVSFQIDTDWKLGFIGRNGRGKTTLFNLLLDKFEYRGKIISSVDFNYFPYPVEDKSKYTHEILEEICPQAEDWEFLREIAYLNVDAEAMYRPFETLSNGEQTKVLLVALFLNEGQFLLIDEPTNHLDTEARKTVSNYLRKKKGNILISHDRNFLDGSVDHILSINRADIEVQSGNYSSWKLNFDRQQGHEQATNERLQKDIGRLEQSTKRSAGWSNRVEASKNGTTNSGSKLDKGFVGHKAAKMMKRSKNLEARQQKSIEEKSKLLKNIEKTESLQFEPVEYKSKELIQLTDVSVIYDGQVVNKPISFNVEQGDRIVLDGKNGSGKSSILKLILGDPIQYTGTLNTGSNLITSYVQQDTSHLKGMLADFIEENEIDESLFKAILRKLDFDRVQFEKDISHYSGGQKKKLLIAKSLCEKAHLYIWDEPLNFIDIYSRMQIEELIQTFNPTMVFVEHDQTFQETISTKIIKI	173.37	gnl|BL_ORD_ID|1073|hsp_num:0	1161			591	678	clindamycin; pleuromutilin
BGC0000258.1|Prodigiosin_8 # 12884 # 13930 # 1 # ID=1_8;partial=00;start_type=ATG;rbs_motif=AGGA;rbs_spacer=7bp;gc_cont=0.504	BGC0000258.1|Prodigiosin_8 	12884	13930	+	Loose	400	30.8018	Erm(35)	30.99	3000604	protein homolog model	n/a	n/a	macrolide antibiotic; lincosamide antibiotic; streptogramin antibiotic; streptogramin A antibiotic; streptogramin B antibiotic	antibiotic target alteration	Erm 23S ribosomal RNA methyltransferase	ATGACATTAACCAAGCAAGACGCAGTCAACCAGATGATGGGCTTTTTTCAGTCCAAAACGCTGATCACGGCGCTGTCATTAAAGTTGTTTGATCACCTGCGTGATCAGGATCGCAACGCTAAACAGATGGCCGCATTACTCAACTGTCCTTTGCGTTCGAGCGAGCAGTTACTCATTGCCTTGCAGGCGATGGGATATCTTGAAAAACAGGACGGTCTTTATCATTTGCCGCAGGAACACCGGGCGTTTTTGGTCAGCGATGAACCACAGTGGCTGGGATGGCTGGGCCGTCATATCGACACTTTTCTATACCCGCTATGGGGAGAGTTGAAAGCGGCTGTTGAAAACGATACCCACCAGCGCCAGACCGTCTTCGGCGATGATCGAAGCTGGTTCGATATTTTGTACCAAAACCCGGATGACGTGACTGATTTCCAGGAGTTTCTGGGGAAGTTTGCCGCCCCCTTCATCGACGGGTTTATTCAGGATTATGACTTCTCGCAGCATCAGGCATTTTTAGATATTGGCAGTGGAATTGGGAGCTTGCCTATCGCAGTAGCCAATGCCTATTCGGGCGTGAATCTGGCGATTTGCGAGCTGCCCCAAACGTCGACGTTTTTGCGTGACAAGTTGGTTCAGCAAGGTTATGGGCAGCGGATCCAGGTGCTTGAGGGGGATGTGATTAGCGGTGATTTGCCGATTGGCGATTATGACCTGATCCACCTGGGATGGATGCTGCATGACTACGCTCCTGAAACGCAATTGATCATCTTGAAAAATATCTATGATGCGATGCCGGTCGGTGGTCGGTTTATCGCCTCTGAAACGCCGCTGAATGCGGATAAGTCAGGCCCTGAGTTTACCGCACTGTTATCGCTGAACATGCTGGTATCCACCGATGGCGGTATCGAAAGCAGTCCTCAGGAGTATTTGTCCCGGTTTCATCAGGCAGGATTCAGCAATGCCCGGATCATGGATATATCCGGTCCTCGTACACTGATAGTCGGCGAGAAAACAACGCATAACAACGGGAGTTCACAATGTTAG	MTLTKQDAVNQMMGFFQSKTLITALSLKLFDHLRDQDRNAKQMAALLNCPLRSSEQLLIALQAMGYLEKQDGLYHLPQEHRAFLVSDEPQWLGWLGRHIDTFLYPLWGELKAAVENDTHQRQTVFGDDRSWFDILYQNPDDVTDFQEFLGKFAAPFIDGFIQDYDFSQHQAFLDIGSGIGSLPIAVANAYSGVNLAICELPQTSTFLRDKLVQQGYGQRIQVLEGDVISGDLPIGDYDLIHLGWMLHDYAPETQLIILKNIYDAMPVGGRFIASETPLNADKSGPEFTALLSLNMLVSTDGGIESSPQEYLSRFHQAGFSNARIMDISGPRTLIVGEKTTHNNGSSQC	MTKKKLPVRFTGQHFTIDKVLIKDAIKESNINQHDTVLDIGAGKGFLTVHLLKNVDKVIAIENDVALSQHLRKKFIHAQNVQVVSCDYRNFVVPKVPFKVVSNIPFGITSDIFSSLMFENVEYFLCGSIILQSEPAKKLFSSKVYNPLTVLYHTYYDLKFLYEINPESFLPPPTVKSALLRIERKQISLDIGLKVKYLNFVSYMLQKPDLTVKTAMKSIFRKKQVRSISEKFGVDLNSKIVCLTPNQWKNCFLEMLEVVPEKFHPS	130.83	gnl|BL_ORD_ID|1315|hsp_num:0	1434			60	261	erythromycin; roxithromycin; lincomycin; telithromycin; clarithromycin; clindamycin; tylosin; spiramycin; azithromycin; dirithromycin; pristinamycin IA; quinupristin; virginiamycin M1; madumycin II; griseoviridin; dalfopristin; pristinamycin IB; virginiamycin S2; pristinamycin IC; vernamycin C; patricin A; patricin B; ostreogrycin B3; oleandomycin
BGC0000258.1|Prodigiosin_9 # 13924 # 14187 # 1 # ID=1_9;partial=00;start_type=ATG;rbs_motif=GGA;rbs_spacer=7bp;gc_cont=0.473	BGC0000258.1|Prodigiosin_9 	13924	14187	+	Loose	3000	26.5646	abcA	42.11	3003942	protein homolog model	n/a	n/a	cephalosporin; penam; peptide antibiotic	antibiotic efflux	ATP-binding cassette (ABC) antibiotic efflux pump	ATGTTAGAAAGTAAATTGATAAACCATATTGCTACTCAGTTTTTGGATGGTGAAAAGGATGGCCTGGATAGCCAAACACCCTTGTTTGAGCTGAATATAGTTGACTCGGCTGCAATTTTTGATCTGGTGGATTTTTTAAGGCAAGAGAGCAAGGTCTCGATTGGCATGCAAGAGATTCACCCGGCAAATTTCGCCACCGTGCAGAGTATGGTTGCGCTGGTGCAACGGCTGAAGGCGCATCCGGAGCAGGGAGGTGCGGCATGA	MLESKLINHIATQFLDGEKDGLDSQTPLFELNIVDSAAIFDLVDFLRQESKVSIGMQEIHPANFATVQSMVALVQRLKAHPEQGGAA	MNESHEAGKNSSTNVEEREEEVLRLARQFTEQSSYSTAGQTPFAAEAGSALDPNGERFNARAWCKAMLQMHIGDKEAHPLRTLGVAFSNLNVHGFGSDTDYQKSVGNVWLKTLSLARIAFGQKQRKVDILQNLEGLVEAGEMLVVLGPPGSGCSTFLKTIAGETYGFHVDKNSNINFQGIAKQMAHEFRGEAIYTAEVDVHFPKLTVGDTLYFAARARTPRHIPGGVNATQYAGHMRDVIMAMFGISHTKNTIVGNDFIRGVSGGERKRVSIAEACLSNAPLQCWDNSTRGLDSANAIEFCKTLRMQADINGTTACVSLYQAPQAAYDYFDKVLVLYEGREIYFGPTSMAKHYFLQMGFVCPDRQTDADFLTSMTSHLERVVQPGYEDRVPRTPDEFAARWKASPQRAQLMQHIKSYNAKFALDGEYLDKFKQSRRAQQAKAQRVSSPYTLSYVQQVKLCLWRGYQRLKADPSVTISSLFGNTIISLVIASIFYNLKADTSTFFQRGALLFFAVLMNALGCGLEMLTLYAQRGIIEKHSRYALYHPSAEAFSSMIMDLPYKILNAITSNIVLYFMTNLRREPGAFFFFVFTSFILTLTMSMFFRSMASLSRSLVQVLPFSAVLLLGLSMYTGFAIPTGYMLGWARWIAYINPISYGFESLMINEFHNRDFPCMDYVPSGPGYTDVGLNNRVCSTVRSVPGQAFVNGNAYIESAYSYTASHKWRNIGVIFAYMFLLGAVYLVATDFITEKKPKGEILVFPRGHKALKKGKSDEDLEGGGGRSATVEKIGSDGLAMIERQTAIFQWKDVCFDIKIGKENCRILDHVDGWVKPGILTALMGVSGAGKTTLLDVLATRTTMGIISGEMLVDGQPRDESFQRKTGYAQQQDLHLSTATVREALEFSALLRQSAHVPRQEKIDYVTEVIKLLDMTEYADAVIGVPGEGLNVEQRKRLTIGVELAARPQLLLFLDEPTSGLDSQTSWAILDLLDKLKKNGQAILCTIHQPSAMLFQRFDRLLFLQAGGRTVYFGEIGQNSQILIDYFVRNGAPPCPPDANPAEWMLDVIGAAPGSHTSINWFETWRRSPEYARVQEHLAELKHERRHQTNLFRTTSGQKREDKDSYREFAAPFWAQLYQVQVRVFQQIWRSPTYIYSKTALCVLSALFVGFSLFHTPNTIQGLQNQMFGIFMLLTLFGQLIQQIMPHFVAQRALYEVRDRPAKTYSWKAFLIANIVVELPWNSLMSVLMFLCWYYPIGLYRNAEPTDAVHLRGTQMWLMIWTFLLFSSTFAHFMIAAFDAAENAGNLGNLLFLLCLLFCGVLATPDQLPRFWIFMYRVSPFTYLVSGMLSVGISNTNVTCADNEYLRFDPVNGTCGEYMGSYMSNLGGYLADEMATANCSFCPIKETNVFLGRVSSSYSDIWRNFGLMWVFIVFNIFAACSLYWWVRVPRDKKPVAKAE	5.99	gnl|BL_ORD_ID|2167|hsp_num:0	2416			2895	2982	methicillin; daptomycin; cefotaxime; moenomycin A1
BGC0000258.1|Prodigiosin_10 # 14184 # 16145 # 1 # ID=1_10;partial=00;start_type=ATG;rbs_motif=GGA;rbs_spacer=8bp;gc_cont=0.524	BGC0000258.1|Prodigiosin_10 	14184	16145	+	Loose	2200	26.5646	Bifidobacterium bifidum ileS conferring resistance to mupirocin	34.78	3003730	protein homolog model	n/a	n/a	mupirocin-like antibiotic	antibiotic target alteration	antibiotic-resistant isoleucyl-tRNA synthetase (ileS)	ATGAACGATGTAACGACCGAGACCTATGAAACCCTGAAACAATCTGTATTGCACACCTTCGCGCAATTGACCGGATACAACGTGTCAGAGCTATCGTTAACCAGCCATTTGGAAAATGATCTGGGGGTGGATTCCATCGCGTTGGCAGAGATTGCCGTCTCGCTGAGCAGACAGTTTCAGCTTAATACGCCATTGTTGATTCAGGATATAAACACCATCAAGGACGCGCTTGACGGCATTTTGCAACGCGAGTTTCAATTGTCGGAAAAGGTCGAGCCGGCAGCAATTGCTCTCTCCGGGGACGCTGACCTTTGGCTTGGTAATCTTGTCCGTCAGATCTTTGCCAGCCATAGTGGCTATGATGTTAATGCGCTGGCGCTGGATGCTGAAATCGAAAGTGATCTGGGGATCGACTCGGTGTCGGTGGCGTCCGCTCAGGGTGAACTATTCAATACGCTGCAATTAAATAGCGAAACCATCATCGCGAACTGCAACACGCTGTCAGCGTTGAAGCAGTGTTTAGCGGCGCGTCTGGTGCAAGAAAAAGGTCAGGATTGGTTTGAACAACGTGGGAGAGGGCAATCCGACTCCGCCATTGACCATGATGCCGACACGACGGCGGAGGTGACTCCGCCAACAGCGACACCCGTCGCGATCAATGCCGAGATCGGCGATCCACGCACCATGCGTGATTTTGTGGGAATAGAACATCCGGATATTTTCCACAAGGCGCGGGAATTCCACCTCTTTTATCAGGATAAAAAGAAACGGCAGCTCTATTTCTATGGCATGCCGCTGGAGACGCCGTGTAAAAACCGGGCCGTTATGTTTGATGAAGCAACCGGTCAACACCGTGAGTTTTTAATGTTTGGCTCCAACAGCTACCTGGGGTTGTCGAATCATCCGGAAATCATTCATGCCATCCAGGATGCGGCCAGCTTATATGGGGCCACCAATACCGGCTGTCGTATTATCGCTGGCAGTAATGTGCTGCATTTAGAGCTGGAGCGCAAACTGGCCAAACTTAAAGGTCGTGATGATTGCATTGTGTATCCTTCCGGTTACTCAGCCAACCTGGGGTGCATCTCGGCGCTGACCAGCAGACACGATTTGGTGTTTACCGATGCCATCAATCACATGAGTATTCAGGATGGCTGTAAGCTGGCTGGCGCGCAGCGCAAGATCTACAATCACTCCTTGACCAGTCTGGAAAAATCCCTGGCCAAATATGCTGATCATCCTGGCGGTAAACTGATTGTGACCGATGGGGTGTTCAGTATGCATGGCGACATTGTCGACCTGCCCAGGTTGATGAAGCTGGCCGAGCGTTACGGCGCACGCGTGTTGGTGGATGATGCGCACTCCACTGGCGTTTTAGGGAAAACCGGGGCGGGGACATCGGAACACTTCAATATGAAAGGTCAGGTGGATCTGGAACTGGGAACCATGAGTAAAGCGCTGTCCGGTCTGGGAGGCTATGTCTGTGGTGATGGCGACGTGGTTGAGTATTTGCGCTTTTATTCCAACTCCTATGTCTTTGCCGCCACCATTCCGGCACCCGTGGCGGCGGGAGTGATCGCCTCAATTGATGTGATGCTGCGTGAACCCGAGCGTTTAGCCAAACTGTGGGACAATATTTACTACTTCCGCACCCGATTACTCAATGCCGGTTTTGATCTTGAGAACTCTGATTCGGCCATTATTCCGATTGTGGTCGGCGATGATGCCAAGACGCTCTTCTTTGGTCGAGCGGTTCGGGCGCGGGGAATGTTTTGCCAAACGGTCGTCTTCCCTGGTGTCAGCGTAGGGGATGCGCGGTTACGCATTAGCATCACCTCTGAACACACTCGGGAAGATTTGGACGAAGCGTATGCGATCCTGGTGGCATCGGCTCTGGAAGTCGGTGTGCCGGTTAATGCATCCGCTCATCAGGAAGAGAACGCGAGTGTCGCGGAGGCTTAA	MNDVTTETYETLKQSVLHTFAQLTGYNVSELSLTSHLENDLGVDSIALAEIAVSLSRQFQLNTPLLIQDINTIKDALDGILQREFQLSEKVEPAAIALSGDADLWLGNLVRQIFASHSGYDVNALALDAEIESDLGIDSVSVASAQGELFNTLQLNSETIIANCNTLSALKQCLAARLVQEKGQDWFEQRGRGQSDSAIDHDADTTAEVTPPTATPVAINAEIGDPRTMRDFVGIEHPDIFHKAREFHLFYQDKKKRQLYFYGMPLETPCKNRAVMFDEATGQHREFLMFGSNSYLGLSNHPEIIHAIQDAASLYGATNTGCRIIAGSNVLHLELERKLAKLKGRDDCIVYPSGYSANLGCISALTSRHDLVFTDAINHMSIQDGCKLAGAQRKIYNHSLTSLEKSLAKYADHPGGKLIVTDGVFSMHGDIVDLPRLMKLAERYGARVLVDDAHSTGVLGKTGAGTSEHFNMKGQVDLELGTMSKALSGLGGYVCGDGDVVEYLRFYSNSYVFAATIPAPVAAGVIASIDVMLREPERLAKLWDNIYYFRTRLLNAGFDLENSDSAIIPIVVGDDAKTLFFGRAVRARGMFCQTVVFPGVSVGDARLRISITSEHTREDLDEAYAILVASALEVGVPVNASAHQEENASVAEA	MSETTNSHVYPKANEGGETASVAPNPSFPNMEETVLKYWDKDDTFNKSVERNPSGDHSQNEFVFFDGPPFANGLPHYGHLLTGYAKDVIPRYQTMKGRKVNRVFGWDTHGLPAELEAQKELGIDSVDQIEKMGIDKFNDACRASVLKYTHEWQDYVHRQARWVDFEHGYKTLNIPYMESVMWAFKQLYEKGLAYQGYRVLPYCPKDQTPLSAHELRMDADVYQDRQDTTVSVAVKLRDEEDAYAVFWTTTPWTVPTNFAIVVGADIDYVEVRPTQGKYAGKKFYFGKPLLSKYEKELGEDYEVVRELKGSEMAGWRYWPVFPYFAGDKAESEGNVPGPEGYQIFTADYVDTVEGTGLVHQAPYGEDDMNTLNAHGIKSTDVLDAGCRFTAQCPDYEGMYVFDANKPILRNLRNGDGPLAEIPAEHRAILFQEKSYVHSYPHCWRCATPLIYKPVSSWFVSVTKIKPRLLELNQQINWIPENVKDGQFGKWLANARDWSISRNRFWGSPIPVWVSDDPKYPRVDVYGSLEELKADFGDYPRDKDGNVNMHRPWIDNLTRVNPDDPTGKSHMHRISDVLDCWFESGSMSFAQFHYPFENKEKFEQHFPADYIVEYIGQTRGWFYLLHVMATALFDRPAFKNVICHGIVLGSDGQKMSKHLRNYPDVNGVFDKYGSDAMRWFLMSSPILRGGNLIVTAEGIRDTVRQVMLPVWSSYYFFTLYANAANGGAGFDARQLRADEVAGLPEMDRYLLARTRRLVERVEKSLDEFAISDACDAASDFIDVLTNWYIRNTRDRFWKEDVNAFNTLYTVLEVFMRVLAPLAPMESESVWRGLTGGESVHLADWPYVADEKTGEATELGRVLVDDPALVDAMEKVREIVSGALSLRKAAQIRVRQPLAKLTVVVEDVDAVKAYDEILKSELNIKDIEFCTMEDAGSQGLKIVHELKVNARAAGPRLGKQVQFAIKASKTGAWHVDAATGAPVVETPNGEVALEAGEYELINRVEEENAAEADASVSAALPTGGFVILDTVLTADLEAEGYARDVIRAVQDARKAADLDIADRIALVLTVPSANVADVERFRDLIAHETLATSFAVKEGAELGVEVAKA	58.99	gnl|BL_ORD_ID|4694|hsp_num:0	2278			288	414	mupirocin
BGC0000258.1|Prodigiosin_11 # 16149 # 17624 # 1 # ID=1_11;partial=00;start_type=ATG;rbs_motif=GGA;rbs_spacer=10bp;gc_cont=0.539	BGC0000258.1|Prodigiosin_11 	16149	17624	+	Loose	1000	150.214	almE	29.24	3007433	protein homolog model	n/a	n/a	peptide antibiotic	antibiotic target alteration	polymyxin resistance operon; alm glycyltransferase	ATGACAATATCCACTCCCGTGATTATCGACAGTCTCATCAGGCACGCCCAGCGAACGCCAGAACAGACAGCCTTGTTGTGTGGTGATCAACACTGGAATTATCGGCAATTGGTCACTCGTGCTCACGTTATGGCCTCGGCCCTGCGACAGGCCGGATTATCGGGTCAGGCCATTTTGCTTAATCTGCCGAAAAGTCTGGATGCGGTTGCGGCGATATATGCCACCTGGCTAAGTGGTAACCACTACATTCCTATTGACTATAGTCAGCCGTCATCACGTATTGAACGCATTATTGCCGCTGCCGCCCCGGCGTTGATTATTGATACAGCGTGGTTAGCCACACTCGATAGCCAACCCTCTTTCGATGCGGAGCAACCAGTTGGGCGTATGGTGTACCACAATCCCATCGCTGCCATTTTATATACCTCCGGCTCGACAGGCACCCCGAAAGGGGTGCAAATCAGCCACGAAATGCTGGGCTTTTTTATCCAGTGGGCGGTGCGGGATACGCAACTGACAGCGCGGGATGTGCTGTCCAATCACGCCAGTTTTGCGTTTGATTTAAGTACCTTTGACCTGTTTGCCAGTGCTTATGTCGGTGCTGCCACCTGGATTATTCGCGAAAGCGAACAGAAAGATTGCGCCGCGTTGGCACAGGGGCTGCAAAGACATGCGGTGTCGGTGTGGTACAGCGTGCCTTCCATTTTAGCCATGCTGGAAAAAAGTACACTGTTGAACCCGACGCTCGGCCAATCTCTGCGGCAAGTCATTTTCGCTGGCGAGCCCTATCCGGTCACTGCGTTAAAACGGCTCTTGCCTTGTTTGCCTCAGCCATGCCGGGTCAGTAACTGGTATGGCCCCACAGAAACCAATGTCTGCGTGGCCTATGCGATTGATCGGGCGCGACTGGCTATGTTGAAACAGGTGCCGATTGGACTTCCCCTTGAAGGACTGACGGCACAGCTCGAAGATGAAAATGGTGACCGACATCCGCTGACGGCACAACTGCGCTTAAGCGGCGAGTTGCTGATCAGCGGGCCGTGTGTGACGCCGGGCTACAGCAATGTGGTCGTTCCCCGGCAGGCCGCTTTGCATCCACATCAATGCCATGCCACCGGGGACTGGGTAGAGATGACGCCAGAGGGTCTGGTATTCCGTGGCCGTATTGATGATATGGTCAAAATCAATGGTTATCGAGTGGAGTTAGGCGAGATTGAATCGGTACTTCATCAGCATCCGGCGATTGATCGGGCGGCGCTATGTGTCGAACTTGGGGATCTCCGGCAGACGTTAATCATGGTGATCAGTCTACAGACTGGCGCAGTGCCGCCGGGTCTGCTGGAACTAAAACAGTTCCTGCAACAGAAACTTCCCTCTTATATGATCCCCAATAAGCTGGTGATCACCGAGAGTTTGCCGGTTAACGCCAATGGCAAGGTTGATCGTAAGCAGTTAGCCGGGGTGGTTGCGGTATGA	MTISTPVIIDSLIRHAQRTPEQTALLCGDQHWNYRQLVTRAHVMASALRQAGLSGQAILLNLPKSLDAVAAIYATWLSGNHYIPIDYSQPSSRIERIIAAAAPALIIDTAWLATLDSQPSFDAEQPVGRMVYHNPIAAILYTSGSTGTPKGVQISHEMLGFFIQWAVRDTQLTARDVLSNHASFAFDLSTFDLFASAYVGAATWIIRESEQKDCAALAQGLQRHAVSVWYSVPSILAMLEKSTLLNPTLGQSLRQVIFAGEPYPVTALKRLLPCLPQPCRVSNWYGPTETNVCVAYAIDRARLAMLKQVPIGLPLEGLTAQLEDENGDRHPLTAQLRLSGELLISGPCVTPGYSNVVVPRQAALHPHQCHATGDWVEMTPEGLVFRGRIDDMVKINGYRVELGEIESVLHQHPAIDRAALCVELGDLRQTLIMVISLQTGAVPPGLLELKQFLQQKLPSYMIPNKLVITESLPVNANGKVDRKQLAGVVAV	MPYNSATDLLQREGYGVVHNQFINKMAMCCETRHSILAAIQANRHAPALWVKQKTYTYQEMTDMALSLSDYWHLQGVQRVAILSVRDLAAYSAIWASYLGGMTYIPLNARATTEQIQETLIATQCDSIMVDAQQLSRLSSLLDTCIDRLHIYALPDVDMEPLRQQYPQHTFHTVQITEQDVELLVAKYHLDNEHEYAYIMQTSGSTGKPKRIAVSYSNLHCYISQIDKLFPLNAQDRVGQYSDLTFDLSVHDIFYSLISGACLYVVPELAKLSPAEFIRHHQLTVWLSVPTVIELALQRQTLTPHSLPSLRLSFFCGQALLHDLAEQWQQATQQPVINLYGPTECTIAITYHRFVAHSGMASVPIGRAFEEECLAIINEQGELMRFESAPEGYRGELLLSGKQLVNGYLNDPLNTQSAFFQHEGRIWYRSGDIVTKSNGVLIHLGRRDHQVKIAGQRVELEEIETVVRRVTQAHSVAIVPWPLSESGYASGTVAFVDTHTQWQPDLWLSQCKQQLNPTFVPKRWYAIEQLPRNANGKTDIKALQQQLASQTYETSH	88.31	gnl|BL_ORD_ID|4935|hsp_num:0	5928			141	1644	colistin A; colistin B
BGC0000258.1|Prodigiosin_14 # 20245 # 20934 # 1 # ID=1_14;partial=00;start_type=ATG;rbs_motif=GGA;rbs_spacer=6bp;gc_cont=0.549	BGC0000258.1|Prodigiosin_14 	20245	20934	+	Loose	700	25.409	FOX-2	27.36	3002156	protein homolog model	n/a	n/a	cephalosporin; cephamycin	antibiotic inactivation	FOX beta-lactamase	ATGGTTATCCATCATAAAGACGGCGTGCCGCCATGGGTTAAGCACGGGCATCATCATCGAGGTATTACCATTTCGGTTGCCGAATGCCACACGATAGGGGTTGCCCTACAACAACGGATGGTGAAACAGCGGGCACGTGAACTGGCGGTAGCGCTGTTGAATCGGGTTTGGCAAACCGGGGATGGCGCCTCTCAGATGGCGGGTTTTACACTGACTCATCGGCCGAGTGGTCAGCCGGTGGGTGAACATCCCCTGTTGGGCGAATATGCGGTGTCGATCAGCCATTCGCATTCATGGTATGCCGGGGCGACCAGCGACACTGCGGTGGGAATCGACCTTCAGCAGTATCGCACTTTTGGTACAACGGCGTGGCGTTACGCCTTTGCTGCCGGTGAACAGCATTGGGGCCGGGTTCAGGCGTGTGCGGCCTGGGCCATTCGGGAAGCATTTTTAAAAAGTCATGGTTGTGGACTTCCCTATCGGCTCAGCGATATCCGGATCGATTGGCATAATGCGTTGGTATCGCATCCTGACCAACTGGAGTGCCGGCAGTTTTGGTTGTGGTATAGCCTGGATTGGGTATGCGCACTGTGTTTTCCGCTACAGGGATCATTGATGACTGACACGGATATTGTGGTGGTTCCCGGTGGGTCTATTGAGCGACAAGGGGAATCTCATCATGGTGAATGA	MVIHHKDGVPPWVKHGHHHRGITISVAECHTIGVALQQRMVKQRARELAVALLNRVWQTGDGASQMAGFTLTHRPSGQPVGEHPLLGEYAVSISHSHSWYAGATSDTAVGIDLQQYRTFGTTAWRYAFAAGEQHWGRVQACAAWAIREAFLKSHGCGLPYRLSDIRIDWHNALVSHPDQLECRQFWLWYSLDWVCALCFPLQGSLMTDTDIVVVPGGSIERQGESHHGE	MQQRRALALLTLGSLLLAPCTYASGEAPLTAAVDGIIQPMLKEYRIPGMAVAVLKDGKAHYFNYGVANRESGQRVSEQTLFEIGSVSKTLTATLGAYAAVKGGFELDDKVSHHAPWLKGSAFDGVTMAELATYSAGGLPLQFPDEVDSNDKMQTYYRSWSPVYPAGTHRQYSNPSIGLFGHLAANSLGQPFEKLMSQTLLPKLGLHHTYIQVPESAMANYAYGYSKEDKPIRVTPGVLAAEAYGIKTGSADLLKFVEANMGYQGDAALKSAIALTHTGFYSVGDMTQGLGWESYAYPVTEQALLAGNSPAVSFQANPVTRFAVPKAMGEQRLYNKTGSTGGFGAYVAFVPARGIAIVMLANRNYPIEARVKAAHAILSQLAE	59.95	gnl|BL_ORD_ID|702|hsp_num:0	764			111	411	
BGC0000258.1|Prodigiosin_15 # 20924 # 22003 # 1 # ID=1_15;partial=00;start_type=ATG;rbs_motif=GGA;rbs_spacer=8bp;gc_cont=0.531	BGC0000258.1|Prodigiosin_15 	20924	22003	+	Loose	2000	25.7942	adeJ	24.53	3000781	protein homolog model	n/a	n/a	macrolide antibiotic; fluoroquinolone antibiotic; lincosamide antibiotic; carbapenem; cephalosporin; tetracycline antibiotic; rifamycin antibiotic; diaminopyrimidine antibiotic; phenicol antibiotic; penem	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	ATGGTGAATGACACATTTGAACAAGCATTGCAAAACGCCATTAATATCGCACGGTTAGCGCCATCATCACATAATTGCCAGCCTTGGTCTGTTCACTACGATGCGGCTACCCGATGTGGTGAAGTCTCGATTGATCGGCAGCGCGCCCTCAAGGGATTACCCTCGCTGGAGCGCGAGATGCTGATGAGTTGTGGGATCTTCTTTGAATACTTGAGTACGTTGCTCAAGCATTCAGGCTATCCGCTTGACTGGCAGTGGGTGGGGGCGCGGCAGAACGGCTCGAGCGGTATGTTGATATCGTTTGCGCCGAGTGCGCCATGTGTCGCTGATCTGGTGGCTTATCAGCAATGGGTGCAAAGGATCAGCGATCGGCATACGGTCAGAACGGCCTATCAGCCGACACAGGTGAATGAACAACAACAGGCACAACTATACGCGTTATTTGACCGTTCACCGGTGACCTGCGACATCAAATATGGCGAAGCAACGCGTCATGACGTCGCTTTTCTCACGGCAAACTATGCATCGCTTGATTTTGCCGATCAACAGGCCTGGCGGGAAACCTATCACTATATTCGGTTCAATGAGCAGCAGGCCGCCGAAGATGGGTTTTATCTGCATCATTTGTTTGGGCCGGTATCATGCGGATTTAGGTGGTTTTTCCGGATTGCGTTTCACCCCAGGCTAAGCTGGCTGGCAAAACGATTGCGATTGCCTGCTTCCATGGCGAAAGGGCTAGCCGAACTGGTGGTGGAAGGCCCGCAATACCTGGCGTTGAGTCTTGAACATGAGAGCGACGAAAATCTGTTTATCGCCGGAATGAAGCTTGGCCAACTGTGGCTGATGTTACAGTCGTGGGGGTGGAGCTTGCATCCGCTCAGTGTGCTGGTGCAGCACGCCACTGCGCGGTGCGCTTTGGCTGACACTGTCCGGCTTACCGGCTTACCGGTTTTTTTTGCGCGTTTTGGCCAGCACCGTCAGTCGGGAATACCCACTCCAAGACGCGCCTGGCAGCGTATTTTAACCACAACACAGCATAGTTTCTCCCCTGAAAACGGGGCTGATGTAAAACAACCCTAA	MVNDTFEQALQNAINIARLAPSSHNCQPWSVHYDAATRCGEVSIDRQRALKGLPSLEREMLMSCGIFFEYLSTLLKHSGYPLDWQWVGARQNGSSGMLISFAPSAPCVADLVAYQQWVQRISDRHTVRTAYQPTQVNEQQQAQLYALFDRSPVTCDIKYGEATRHDVAFLTANYASLDFADQQAWRETYHYIRFNEQQAAEDGFYLHHLFGPVSCGFRWFFRIAFHPRLSWLAKRLRLPASMAKGLAELVVEGPQYLALSLEHESDENLFIAGMKLGQLWLMLQSWGWSLHPLSVLVQHATARCALADTVRLTGLPVFFARFGQHRQSGIPTPRRAWQRILTTTQHSFSPENGADVKQP	MAQFFIHRPIFAWVIALVIMLAGILTLTKMPIAQYPTIAPPTVTIAATYPGASAETVENTVTQIIEQQMNGLDGLRYISSNSAGNGQASIQLNFEQGVDPDIAQVQVQNKLQSATALLPEDVQRQGVTVTKSGASFLQVIAFYSPDNNLSDSDIKDYVNSSIKEPLSRVAGVGEVQVFGGSYAMRIWLDPAKLTSYQLTPSDIATALQAQNSQVAVGQLGGAPAVQGQVLNATVNAQSLLQTPEQFKNIFLKNTASGAEVRLKDVARVELGSDNYQFDSKFNGKPAAGLAIKIATGANALDTAEAVEQRLSELRKNYPTGLADKLAYDTTPFIRLSIESVVHTLIEAVILVFIVMFLFLQNWRATIIPTLAVPVVVLGTFAVINIFGFSINTLTMFAMVLAIGLLVDDAIVVVENVERVMSEDHTDPVTATSRSMQQISGALVGITSVLTAVFVPMAFFGGTTGVIYRQFSITLVTAMVLSLIVALTFTPALCATILKQHDPNKEPSNNIFARFFRSFNNGFDRMSHSYQNGVSRMLKGKIFSGVLYAVVVALLVFLFQKLPSSFLPEEDQGVVMTLVQLPPNATLDRTGKVIDTMTNFFMNEKDTVESIFTVSGFSFTGVGQNAGIGFVKLKDWSKRTTPETQIGSLIQRGMALNMIIKDASYVMPLQLPAMPELGVTAGFNLQLKDSSGQGHEKLIAARNTILGLASQDKRLVGVRPNGQEDTPQYQINVDQAQAGAMGVSIAEINNTMRIAWGGSYINDFVDRGRVKKVYVQGDAGSRMMPEDLNKWYVRNNKGEMVPFSAFATGEWTYGSPRLERYNGVSSVNIQGTPAPGVSSGDAMKAMEEIIGKLPSMGLQGFDYEWTGLSLEERESGAQAPFLYALSLLIVFLCLAALYESWSIPFSVLLVVPLGVIGAIVLTYLGMIIKGDPNLSNNIYFQVAIIAVIGLSAKNAILIVEFAKELQEKGEDLLDATLHAAKMRLRPIIMTTLAFGFGVLPLALSTGAGAGSQHSVGFGVLGGVLSATFLGIFFIPVFYVWIRSMFKYKPKTINTQEHKS	33.93	gnl|BL_ORD_ID|574|hsp_num:0	630			2811	3096	tetracycline; rifampin; imipenem; trimethoprim; chloramphenicol; ticarcillin
BGC0000258.1|Prodigiosin_16 # 22022 # 22750 # 1 # ID=1_16;partial=00;start_type=ATG;rbs_motif=AGGA;rbs_spacer=7bp;gc_cont=0.477	BGC0000258.1|Prodigiosin_16 	22022	22750	+	Loose	275	26.1794	AAC(6')-Ii	21.05	3002556	protein homolog model	n/a	n/a	aminoglycoside antibiotic	antibiotic inactivation	AAC(6')	ATGGACGTTTGGATTGCAGTGGTTGTCGTATTATTAGTCATGTCTTTTCTGGCCTTCGTGACGAGCCAAAAGGCACGGGATACCCGGCCGATGTTTTTGTGGGGATTCAATGCGATGGGGCCGGTTGCCTTGGTATTTTGCTATTTTGGTGGGGGTGATATAAACCATAAAGCTCTGATCCTGGCCTTTGTCGGTATTTATCTACTTCATATGAATATTGTACTGACACTCTGGTACGGCAATACTGCTGCATCCAAACTCAAGGATGTGTTACCCACACAACAGGTGCCGTTATTGGCGGTGATGATGGTGAACATCTTCGGGTGGTTGTATTGCCTGCCTTTTTACTGGGCCAGTCAATTGCAAGGGCCATTTGGCACAGTTCAATGGGTAGCCATCGTGGTTTATAGTCTCGGCACCCTCTATCACTTTGGCGGCGACTACCAAAAGCGCCGCTTCAAACAAAATCCGCAAAATAAAGGCCAGATCCTCTGCTCCGGGTTTTGGGCGACGTCTCGTCATCCCAATTATTTTGGCGACTTTCTGATTTTTGCCAGTTTCGGACTGCTGGCGGGCAACTGGTTTGGGGTAATTGCGCCGCTGACCAATATTGTCCAATACTTCGCTGATGCGATTCCCAAAAGTGAGAAAATGGCCGAACAGCGCTATGGTAACGCCTGGCTTGACTATAAAAGGAAAGTGAAGTGCTTTATCCCCTTTATCTTTTAG	MDVWIAVVVVLLVMSFLAFVTSQKARDTRPMFLWGFNAMGPVALVFCYFGGGDINHKALILAFVGIYLLHMNIVLTLWYGNTAASKLKDVLPTQQVPLLAVMMVNIFGWLYCLPFYWASQLQGPFGTVQWVAIVVYSLGTLYHFGGDYQKRRFKQNPQNKGQILCSGFWATSRHPNYFGDFLIFASFGLLAGNWFGVIAPLTNIVQYFADAIPKSEKMAEQRYGNAWLDYKRKVKCFIPFIF	MIISEFDRNNPVLKDQLSDLLRLTWPEEYGDSSAEEVEEMMNPERIAVAAVDQDELVGFIGAIPQYGITGWELHPLVVESSRRKNQIGTRLVNYLEKEVASRGGITIYLGTDDLDHGTTLSQTDLYVHTFDKVASIQNLREHPYEFYEKLGYKIVGVLPNANGWDKPDIWMAKTIIPRPDSQ	132.97	gnl|BL_ORD_ID|1042|hsp_num:0	1050			84	198	dibekacin; amikacin; sisomicin; netilmicin; tobramycin; 2'-N-ethylnetilmicin; 5-episisomicin
BGC0000258.1|Prodigiosin_17 # 22726 # 22881 # 1 # ID=1_17;partial=00;start_type=GTG;rbs_motif=AGGA;rbs_spacer=7bp;gc_cont=0.417	BGC0000258.1|Prodigiosin_17 	22726	22881	+	Loose	650	25.7942	cfrE	43.75	3005023	protein homolog model	n/a	n/a	lincosamide antibiotic; streptogramin antibiotic; oxazolidinone antibiotic; phenicol antibiotic	antibiotic target alteration	Cfr 23S ribosomal RNA methyltransferase	GTGCTTTATCCCCTTTATCTTTTAGTGGATAGCTCAGGGAACAGTAGCGGTTTGATTAACGATAGCCTGGGGCATCTAAGGTCACTCTTTCATGGCATATGCTCTATTCAAGCGGTAAAATATTGCCACCATCTACTGTTAATGAGCATCAAATGA	MLYPLYLLVDSSGNSSGLINDSLGHLRSLFHGICSIQAVKYCHHLLLMSIK	MIYSKYEVMKRCISGMNFPDYRYEQLIKMIFAQHIPDFHSMYMLPERLRSNLAETFGTSVCGLVPVTHRASGQADKVLFQLKDGNCVETVNLHYKKGWESFCVSSQCGCGFGCKFCATGAIGHKRNMTADEITDQILYFYLAGHQINSVSFMGMGEPFANPNLFDALKILTNPSLFGLSQRRITISTIGMIPGIKRLTRDFPQVNLAFSLHSPFEKQRSELMPINQTYPLHKVMDALDAHVANTKRRLFLAYIMLGGINDSAEHAKALAHLILSRGALSYLYHVDLIPYNATDKTARKFTASNHEAIKNFSDILHSNRISVAIRMQFGSDIGAGCGQLYADERD	14.83	gnl|BL_ORD_ID|4936|hsp_num:0	5914			765	861	
BGC0000258.1|Prodigiosin_18 # 22878 # 23351 # 1 # ID=1_18;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.451	BGC0000258.1|Prodigiosin_18 	22878	23351	+	Loose	200	25.0238	vanX gene in vanP cluster	25.71	3007190	protein homolog model	n/a	n/a	glycopeptide antibiotic	antibiotic target alteration	vanX; glycopeptide resistance gene cluster	ATGATTAAGTTTTCTGAAATCGGCAAGGCTATGACAGAGTTCGAATCCGTCGATGGCGTTCCATTACAAGGATATGGTATCTCCGACTCTCGTGGGACGATCGTGCTTTTTGATGATTACGCCGAAGGATTACAAGATATTGAGGGGTTCTCCCACCTTTATTTGCTGTTTCATCTGCATCGTTCTAATAACCATAGTCTTAAGGTAAAACCGTTCCTGGATACTCAGGAGCGAGGCGTTTTTGCTACTCGCTCACCAAGACGGCCTAATCCACTTGGTCTCACTATTGTGCAATTAGAACGCCGGGAGGGAAATGTCTTGCATGTTCGAGGTCTGGATCTGCTGAACGGCACACCCATTATTGATATCAAACCTTATATTCAAGCTTTCGATAATGTTCAGGGAACCCGTGATGGCTGGTATTTGCAGGGGATGAATCCACATCAGACGCTATCTGACGAGCGTTTTAAATAG	MIKFSEIGKAMTEFESVDGVPLQGYGISDSRGTIVLFDDYAEGLQDIEGFSHLYLLFHLHRSNNHSLKVKPFLDTQERGVFATRSPRRPNPLGLTIVQLERREGNVLHVRGLDLLNGTPIIDIKPYIQAFDNVQGTRDGWYLQGMNPHQTLSDERFK	MKSEFVYLDEVIPGVRWDAKYATWDNFMGMPVNGYQVNRVVGTVEMADALKEVSKLAKEKGVGLLLWDGYRPVRAVSHFMEWVKKSKDESRKAKHYPHIDKKTMIEEGYIAEYSGHSRGSTIDLTLYDLESKKLLDMGGDFDLMDEISHYAAEGITKEEKENRKLLRDLMVKCGFVPYENEWWHYSLKDEPYPDTYFDFVIE	77.72	gnl|BL_ORD_ID|4820|hsp_num:0	5806			84	399	vancomycin; teicoplanin
BGC0000258.1|Prodigiosin_19 # 23442 # 24392 # -1 # ID=1_19;partial=00;start_type=ATG;rbs_motif=GGA;rbs_spacer=6bp;gc_cont=0.451	BGC0000258.1|Prodigiosin_19 	23442	24392	-	Loose	790	25.409	mtrC	24.42	3000810	protein homolog model	n/a	n/a	macrolide antibiotic; penam	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	ATGTCTGGACAAGCCCGCAGCTCATCCGGACCAGAGTATAAAGAGATATCTATGAATTACCATGACCTCAGAAAGATCATAACATTGCGTAAATTGGGCCTAAAAAAGCGTAGCATTTGGAAGATGATGTGGTCTTCTGACGCAACAAAACTAAATTACCCGCAATTTATACAACAGCTACAACAACTCGAATCATCCTATCAGCACAACAAGCTGCATTCAGATAACGAAATCAACAAGCTGTATGCGCTTCTCAAAAAGGATTTTCTTGAGCAAGTTAACAAATTCGATCTTCAGCGGGAAACGTTGCAAATCCGCTGTCAGGCGCTCAGCTCGGTTGAAGCTATTGGTCATCCTCAACATCAGGACTACCCCATTATTCGAGGTCATGAAAAGATGATCGAGGCGGATTTTATGGGGAGCCGGGGCCAGGCGTTTACCGATCACTATCACAATAGCGAGTATTCACTACAGCAGATCCTTGAACTGCCACTGGAGAATGACCAGCAGCGGGCTGATTTTATTGCCGCACTCAATGCAGTTTATCGACACCTGAAACTATGTGATAAGACCGTACATTGTAAAAACGATGAAATCGTCCTGTGCGGCAAACAGGTAGATAGTGCGGTGATGGCAGATCAAAAAATTTTACTGATCGGTCTACAGCCGAGGATTCTGGAAAACTTGTCGAGCAAACAGCCTATTCGGGTAATCGATCTTGATCCGAGCAATATAGGCCAGCACAAATATGGCGTCACCATCGAAGATGAATCGCAGACCGAGACAGCCATCGATTGGTGTGACCAGATCCTGGCAACCGGATCGACGTTGGTTAATGGCACCATCTGCCAATTTTTACAATCTCAAAAACCGGTTACCTTTTTTGGTGTCACGATCTCAGCAGCAGCAAAGATCTTGAATCTGGATCACTACTGCTTTTGTGGGCGCTGA	MSGQARSSSGPEYKEISMNYHDLRKIITLRKLGLKKRSIWKMMWSSDATKLNYPQFIQQLQQLESSYQHNKLHSDNEINKLYALLKKDFLEQVNKFDLQRETLQIRCQALSSVEAIGHPQHQDYPIIRGHEKMIEADFMGSRGQAFTDHYHNSEYSLQQILELPLENDQQRADFIAALNAVYRHLKLCDKTVHCKNDEIVLCGKQVDSAVMADQKILLIGLQPRILENLSSKQPIRVIDLDPSNIGQHKYGVTIEDESQTETAIDWCDQILATGSTLVNGTICQFLQSQKPVTFFGVTISAAAKILNLDHYCFCGR	MAFYAFKAMRAAALAAAVALVLSSCGKGGDAAQGGQPAGREAPAPVVGVVTVHPQTVALTVELPGRLESLRTADVRAQVGGIIQKRLFQEGSYVRAGQPLYQIDSSTYEAGLESARAQLATAQATLAKADADLARYKPLVAAEAVSRQEYDAAVTAKRSAEAGVKAAQAAIKSAGISLNRSRITAPISGFIGQSKVSEGTLLNAGDATVLATIRQTNPMYVNVTQSASEVMKLRRQIAEGKLLAADGVIAVGIKFDDGTVYPEKGRLLFADPAVNESTGQITLRAAVPNDQNILMPGLYVRVLMDQVAVDNAFVVPQQAVTRGAKDTVMIVNAQGGMEPREVTVAQQQGTNWIVTSGLKDGDKVVVEGISIAGITGAKKVTPKEWASSENQAAAPQSGVQTASEAKPASEAK	76.70	gnl|BL_ORD_ID|1232|hsp_num:0	1340			657	909	erythromycin; penicillin; azithromycin
